Part 2: Who to test

Part 3: How to test

Part 4: Metastatic prostate cancer and HRR defects

Part 5: BRCA 1/2 mutations and prostate cancer

The role of testing in prostate cancer treatment

Prostate cancer screening using prostate-specific antigen, a multiplex blood-test, MRI and targeted prostate biopsies

OncoAlert and ecancer weekly round up for July 12- July 18, 2021

Mitomycin and BCG treatment vs BCG monotherapy in patients with non-muscle invasive bladder cancer

Stigma about palliative care

Unmet medical needs and emerging data on EGFR exon 20 insertion mutation NSCLC at ASCO 2021

Lineage plasticity in lung cancer- biological and therapeutic implications

Phase III study of lutetium-177-PSMA-617 in patients with metastatic castration-resistant prostate cancer (VISION)